Latest News about MRK
Recent news which mentions MRK
Why Shares of Keros Therapeutics Rose 10.2% This Week
October 14, 2022
From Motley Fool
Health Care Exposure Ahead Of CPI Data, Progressive, Dollar General And Seagate Technology Feature On CNBC's 'Final Trades'
October 13, 2022
From Benzinga
These 2 Stocks Gave Investors a Nice Surprise Wednesday
October 12, 2022
From Motley Fool
Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?
October 12, 2022
From Benzinga
Why Moderna Stock Is Bolting Higher Today
October 12, 2022
From Motley Fool
Why Is Moderna (MRNA) Stock Up 10% Today?
October 12, 2022
From InvestorPlace
Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot
October 12, 2022
From Benzinga
From Benzinga
Why Moderna Stock Is Moving Higher Today
October 12, 2022
From Benzinga
From Motley Fool
With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade
October 11, 2022
From Benzinga
From Benzinga
Merck Collaborates Ginkgo Bioworks to Improve Active Pharmaceutical Ingredient Manufacturing
October 11, 2022
From Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
October 11, 2022
From Benzinga
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
October 11, 2022
From InvestorPlace
From Benzinga
Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial
October 10, 2022
Tickers
MRK
From Benzinga
Failure Of This Merck Study Is A 'Material Risk' But Analysts Are 'Extremely Bullish'
October 10, 2022
Tickers
MRK
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
From Benzinga
3 Great Dividend Stocks to Buy in October
October 08, 2022
From Motley Fool
Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns
October 07, 2022
From MarketWatch
From Benzinga
Why Guardant Health Topped the Market on Thursday
October 06, 2022
From Motley Fool
Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" Competition
October 06, 2022
From Benzinga
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
October 06, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.